
The infectious effusion, one of the most frequent causes of pleural effusions in the clinical practice, is a sign of complication of the pneumonic disease. The early recognition of the parapneumonic effusion is crucial to determine the best treatment form and reduce the risk of morbidity and mortality. The evolution in the diagnostic methods and the contribution of several studies published in the literature allowed to establish evidence-based guidelines that are used to guide the treatment of the parapneumonic pleural effusion and empyema.
Cross Infection, Evidence-Based Medicine, Combined Modality Therapy, Severity of Illness Index, Anti-Bacterial Agents, Community-Acquired Infections, Pleural Effusion, Risk Factors, Pneumonia, Bacterial, Drainage, Humans, Paracentesis, Thrombolytic Therapy, Empyema, Pleural
Cross Infection, Evidence-Based Medicine, Combined Modality Therapy, Severity of Illness Index, Anti-Bacterial Agents, Community-Acquired Infections, Pleural Effusion, Risk Factors, Pneumonia, Bacterial, Drainage, Humans, Paracentesis, Thrombolytic Therapy, Empyema, Pleural
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
